Nevro (NYSE:NVRO) Now Covered by Wells Fargo & Company

Wells Fargo & Company began coverage on shares of Nevro (NYSE:NVRO – Free Report) in a research report report published on Tuesday, MarketBeat.com reports. The firm issued an equal weight rating and a $5.00 target price on the medical equipment provider’s stock. A number of other analysts have also recently issued reports on NVRO. Truist […]

Leave a Reply

Your email address will not be published.

Previous post Eos Energy Enterprises Secures $303.5 Million Loan Guarantee from U.S. Department of Energy
Next post Eastman Chemical (NYSE:EMN) Upgraded at StockNews.com